Project Number AIA-18-548286 Agency/Funding Organization Alzheimer's Association Funding Year 2018 View Full Project Details for Development of Tau-Lowering Small Molecule Drugs Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator MUCKE, LENNART Principal Investigator First Name LENNART Principal Investigator Last Name MUCKE Awardee Organization J. DAVID GLADSTONE INSTITUTES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2017: AIA RFA FY Overall Cost $150,000 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Snyder, Heather hsnyder@alz.org
